TRX2
TRX2 is a dietary supplement marketed for individuals with hair loss. It is manufactured and sold by Oxford BioLabs in the United Kingdom, marketed in 2011.
Etymology and Formulation
The name TRX2 is said to be derived from the Ancient Greek word trichos, meaning hair and the number 2 stands for second generation. The proper word for hair in Ancient Greek is however thrix.TRX2 contains amino acids and vitamins. Its ingredients are L-carnitine, L-tartaric acid, potassium chloride, L-leucine, isoleucine, valine, nicotinic acid, and biotin.
The product is a dietary supplement, not a drug, and hence it does not need approval by the U.S. Food and Drug Administration.
Oxford BioLabs
Oxford BioLabs was founded in August 2008 as a Limited Liability Company in England and Wales by former scientists of the University of Oxford, including biochemist and entrepreneur Thomas Whitfield. The company have German based Research Facilities located in Biopark Regensburg, Regensburg, Germany. According to an article published by The Daily Telegraph the company is bootstrapped by its founders as well as by NESTA and the National Council for Graduate Entrepreneurship.Clinical Studies
TRX2 has been tested by Oxford Biolabs in a clinical study. In the study, 59 male and female volunteers showing signs of alopecia completed 18 months of therapy, receiving either TRX2 or a placebo.The results of the study showed that 26 participants who had taken TRX2 recorded an increase of at least 10% in the number of hair strands in the evaluation area and/or a 10% increase in hair weight.
The third-party studies took place in 2019 and were conducted by the European Research Institute Dermatest.